The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Cognitive Outcomes Following Contemporary Treatment Without Cranial Irradiation for Childhood Acute Lymphoblastic Leukemia
Open accessAbstract
BACKGROUND: Treatment of acute lymphoblastic leukemia (ALL) has included the use of prophylactic cranial irradiation in up to 20% of children with high-risk disease despite known cognitive risks of this treatment modality. METHODS: Patients enrolled on the St Jude ALL Total Therapy Study XV, which omitted prophylactic cranial irradiation in all patients, were assessed 120 weeks after completion of consolidation therapy (n = 243) using a comprehensive cognitive battery. χ(2) analysis was used to compare the percentage of below-average performers among the entire ALL patient group to the expected rate based on the normative sample. Univariate logistic regression was used to estimate the effect of intensity of chemotherapy (treatment arm), age at diagnosis, and sex on the probability of below-average performance. All statistical tests were two-sided. RESULTS: Overall, the ALL group had a statistically significantly higher risk for below-average performance on a measure of sustained attention (67.31% more than 1 SD below the normative mean for omission errors, P < .001) but not on measures of intellectual functioning, academic skills, or memory. Patients given higher intensity chemotherapy were at greater risk for below-average performance compared with those given lower intensity therapy on measures of processing speed (27.14% vs 6.25%, P = .009) and academic abilities (Math Reasoning: 18.60% vs 3.90%, P = .008; Word Reading: 20.00% vs 2.60%, P = .007; Spelling: 27.91% vs 3.90%, P = .001) and had higher parent-reported hyperactivity (23.00% vs 9.84%, P = .018) and learning problems (35.00% vs 16.39%, P = .005). Neither age at diagnosis nor sex was associated with risk for below-average cognitive performance. CONCLUSIONS: Omitting cranial irradiation may help preserve global cognitive abilities, but treatment with chemotherapy alone is not without risks. Caregiver education and development of interventions should address both early attention deficits and cognitive late effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
Sowell, E. R., Thompson, P. M., Tessner, K. D., & Toga, A. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08819.2001 · Cited by 983
Sex Differences in Brain Maturation during Childhood and Adolescence
De Bellis, M. D. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.6.552 · Cited by 728 · cited 1×
“The mechanism for sex-specific risk is not fully understood but may result from differences in cerebral myelination (21,22).”
BackgroundSex differences in neural processing of language among children
Burman, D. D., Bitan, T., & Booth, J. R. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.12.021 · Cited by 254
Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment
Janzen, L. A., & Spiegler, B. J. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.24 · Cited by 47 · cited 1×
“There is also some evidence (11) to suggest that different chemotherapy regimens carry greater cognitive risk than others based on drugs used (eg, triple intrathecal methotrexate, hydrocortisone and cytarabine [ITMHA] vs intrathecal methotrexate alone; dexamethasone vs prednisone) as well as drug dosage and mode of ad…”
Background
Cited by
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
Armstrong, G. T., Chen, Y., Yasui, Y., Leisenring, W., Gibson, T. M., Mertens, A. C., Stovall, M., Oeffinger, K. C., Bhatia, S., Krull, K. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510795 · Cited by 568
Self-citationPediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui, C.-H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012) · Blood · doi:10.1182/blood-2012-05-378943 · Cited by 500
Self-citationMethotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia
Bhojwani, D., Sabin, N. D., Pei, D., Yang, J. J., Khan, R. B., Panetta, J. C., Krull, K. R., Inaba, H., Rubnitz, J. E., Metzger, M. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0808 · Cited by 400
“Childhood ALL survivors are at risk of neurocognitive impairments, particularly attention disorders.(46) A recent investigation using a candidate SNP approach reported association of attention problems in survivors with polymorphisms in genes involved in oxidative stress and CNS integrity.”
BackgroundSelf-citationA 50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.06.007 · Cited by 368
Self-citationIyer, N. S., Balsamo, L. M., Bracken, M. B., & Kadan-Lottick, N. S. (2015) · Blood · doi:10.1182/blood-2015-02-627414 · Cited by 194
Jacola, L. M., Krull, K. R., Pui, C.-H., Pei, D., Cheng, C., Reddick, W. E., & Conklin, H. M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3205 · Cited by 160
Self-citationKrull, K. R., Cheung, Y. T., Liu, W., Fellah, S., Reddick, W. E., Brinkman, T. M., Kimberg, C., Ogg, R., Srivastava, D., Pui, C.-H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.4574 · Cited by 136
Self-citationMichel, G., Brinkman, T. M., Wakefield, C. E., & Grootenhuis, M. (2020) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.07.005 · Cited by 133
Kanellopoulos, A., Andersson, S., Zeller, B., Tamnes, C. K., Fjell, A. M., Walhovd, K. B., Westlye, L. T., Fosså, S. D., & Ruud, E. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25690 · Cited by 89
“Similar results have been reported from studies with shorter follow-up time[5,6,10,11,33] and a recent long-term study from the St.”
ResultSluggish cognitive tempo in survivors of pediatric brain tumors
Willard, V. W., Hardy, K. K., Allen, T. M., Hwang, E. I., Gururangan, S., Hostetter, S. A., & Bonner, M. J. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1149-8 · Cited by 36
“These findings, in turn, are consistent with recent literature indicating that survivors of ALL generally function within normal limits during the post-treatment period [30, 31].”
Result
Metadata
- Authors
- Conklin, H. M., Krull, K. R., Reddick, W. E., Pei, D., Cheng, C., & Pui, C. H.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-27
- Volume
- 104
- Issue
- 18
- Pages
- 1386-1395
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2130902516
- Cited by
- 162
- References
- 5
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.